Share

Electromagnetic wireless remote control of mammalian transgene expression

Lin Z, Guha Ray P, Huang J. et al.

PAPERmanualNature Nanotechnology2025Animal studyEffect: benefitEvidence: Low

Abstract

Category: Nanotechnology, Biomedical Engineering Tags: electromagnetic fields, transgene expression, wireless control, nanotechnology, ROS, gene therapy, biosensors DOI: 10.1038/s41565-025-01929-w URL: nature.com Overview Communication between wireless field receivers and biological sensors remains a key constraint in the development of wireless electronic devices for minimally invasive medical monitoring and biomedical applications involving gene and cell therapies. Innovation This study describes a nanoparticle-cell interface that enables electromagnetic programming of wireless expression regulation (EMPOWER) of transgenes. This is achieved via the biosafe generation of cellular reactive oxygen species (ROS). - Multiferroic nanoparticles are coated with chitosan to improve biocompatibility. - These nanoparticles generate ROS in the cytoplasm of cells in response to a low-frequency (1-kHz) magnetic field. - Overexpressed ROS-responsive KEAP1/NRF2 biosensors detect the generated ROS and are connected to synthetic ROS-responsive promoters to drive transgene expression. Findings In a proof-of-concept study, subcutaneously implanted alginate-microencapsulated cells stably expressing an EMPOWER-controlled insulin expression system successfully normalized blood-glucose levels in a mouse model of type 1 diabetes in response to a weak magnetic field. Conclusion The research demonstrates a wireless and minimally invasive approach to regulate gene expression in vivo using electromagnetic fields, mediated by biocompatible nanoparticles and ROS-sensitive biosensors. This highlights a direct link between electromagnetic field exposure and physiological regulation at the molecular and cellular level, underscoring the potential health and therapeutic implications of EMF exposure.

AI evidence extraction

At a glance
Study type
Animal study
Effect direction
benefit
Population
Mouse model of type 1 diabetes (subcutaneously implanted alginate-microencapsulated cells)
Sample size
—
Exposure
ELF <1 MHz
Evidence strength
Low
Confidence: 74% · Peer-reviewed: yes

Main findings

Multiferroic nanoparticles (chitosan-coated) generated cytoplasmic ROS in response to a low-frequency (1-kHz) magnetic field, which was detected by ROS-responsive KEAP1/NRF2 biosensors linked to synthetic promoters to drive transgene expression. In a proof-of-concept mouse model of type 1 diabetes, implanted cells with an EMPOWER-controlled insulin system normalized blood-glucose levels in response to a weak magnetic field.

Outcomes measured

  • Transgene expression regulation (insulin expression)
  • Blood-glucose levels normalization
  • Cellular reactive oxygen species (ROS) generation

Limitations

  • Sample size not reported in provided abstract/metadata
  • Exposure intensity and duration not specified in provided abstract/metadata
  • Proof-of-concept design
  • generalizability beyond the described model not stated
View raw extracted JSON
{
  "study_type": "animal",
  "exposure": {
    "band": "ELF",
    "source": "other",
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": null
  },
  "population": "Mouse model of type 1 diabetes (subcutaneously implanted alginate-microencapsulated cells)",
  "sample_size": null,
  "outcomes": [
    "Transgene expression regulation (insulin expression)",
    "Blood-glucose levels normalization",
    "Cellular reactive oxygen species (ROS) generation"
  ],
  "main_findings": "Multiferroic nanoparticles (chitosan-coated) generated cytoplasmic ROS in response to a low-frequency (1-kHz) magnetic field, which was detected by ROS-responsive KEAP1/NRF2 biosensors linked to synthetic promoters to drive transgene expression. In a proof-of-concept mouse model of type 1 diabetes, implanted cells with an EMPOWER-controlled insulin system normalized blood-glucose levels in response to a weak magnetic field.",
  "effect_direction": "benefit",
  "limitations": [
    "Sample size not reported in provided abstract/metadata",
    "Exposure intensity and duration not specified in provided abstract/metadata",
    "Proof-of-concept design; generalizability beyond the described model not stated"
  ],
  "evidence_strength": "low",
  "confidence": 0.74,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "electromagnetic fields",
    "magnetic field",
    "1-kHz",
    "ELF",
    "wireless control",
    "transgene expression",
    "nanoparticles",
    "multiferroic nanoparticles",
    "chitosan",
    "reactive oxygen species",
    "ROS",
    "KEAP1",
    "NRF2",
    "biosensor",
    "synthetic promoter",
    "insulin",
    "type 1 diabetes",
    "mouse"
  ],
  "suggested_hubs": [
    {
      "slug": "other",
      "weight": 0.4,
      "reason": "Biomedical/therapeutic use of low-frequency magnetic fields to control gene expression via nanoparticles; no specific portal hub provided in prompt matches this topic."
    }
  ]
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.

NNEMF synthesis

Synthesis pending.

Original record: rfsafe.org paper 2658

Electromagnetic wireless remote control of mammalian transgene expression · Non-native EMF